ENOV
Enovis Corp
NYSE: ENOV · HEALTHCARE · MEDICAL DEVICES
$22.49
-3.89% today
Updated 2026-04-29
Market cap
$1.35B
P/E ratio
—
P/S ratio
0.60x
EPS (TTM)
$-20.72
Dividend yield
—
52W range
$21 – $38
Volume
1.0M
WallStSmart proprietary scores
56
out of 100
Grade: C+
Hold
Investment rating
7.3
Growth
B+4.8
Quality
C3.5
Profitability
D6.3
Valuation
B3/9
Piotroski F-Score
Weak
0.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$44.73
+98.89%
12-Month target
—
—
Intrinsic (DCF)
$60.01
Margin of safety
+62.01%
2 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $32.29M — positive
+ 62.01% below intrinsic value
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.48 — distress zone
- Thin margins at -52.70%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.56B | $1.71B | $2.11B | $2.25B | $2.25B |
| Net income | $-13.29M | $-33.26M | $-825.49M | $-1.18B | $-520.59M |
| EPS | — | — | — | — | $-20.72 |
| Free cash flow | $-161.31M | $12.77M | $-67.21M | $19.92M | $32.29M |
| Profit margin | -0.85% | -1.95% | -39.17% | -52.69% | -52.70% |
Peer comparison
Smart narrative
Enovis Corp trades at $22.49. Our Smart Value Score of 56/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.48, it sits in the distress. TTM revenue stands at $2.25B. with profit margins at -52.70%. Our DCF model estimates intrinsic value at $60.01.
Frequently asked questions
What is Enovis Corp's stock price?
Enovis Corp (ENOV) trades at $22.49.
Is Enovis Corp overvalued?
Smart Value Score 56/100 (Grade C+, Hold). DCF value $60.01.
What is the price target of Enovis Corp (ENOV)?
The analyst target price is $44.73, representing +98.9% upside from the current price of $22.49.
What is the intrinsic value of Enovis Corp (ENOV)?
Based on our DCF model, intrinsic value is $60.01, a +62.0% margin of safety versus $22.49.
What is Enovis Corp's revenue?
TTM revenue is $2.25B.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
0.48 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL DEVICES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.60x
ROE-58.30%
Beta1.59
50D MA$23.65
200D MA$27.30
Shares out0.06B
Float0.06B
Short ratio—
Avg volume1.0M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—